The prevalence of metabolic syndrome in a local population in India

Biochemia Medica

Volumn 20, Issue 2, 2010, Pages 249-252

  Thiruvagounder, Manopriya ^a   Khan, Shaheen ^b   Sheriff, Dhastagir Sultan ^c  

^a Institute of Research in Science and Medicine   (India)

^b Institute of Cardiology   (India)

^c AL ARAB MEDICAL UNIVERSITY   (Libyan Arab Jamahiriya)

Author keywords

Dyslipidaemia; Glucose into lerance; Metabolic syndrome; Prevalence; Waist circumference

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTION; PREVALENCE; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

EID: 77953839527     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/bm.2010.031     Document Type: Article

References (14)

1. Reaven GM. Role of insulin resistance in human disease (syndrome X). An expanded definition. Ann Rev Med 1993; 44:121-131
2. Blaton VH, Korita I, Bulo A. How is metabolic syndrome related to dyslipidemia? Biochem Med 2008;18:14-24.
3. Meigs JB. Epidemiology of the metabolic syndrome, Amer J Manag Care 2002;8:S283-92.
4. Bloomagarden ZT. American Association of clinical Endocrinologists (AACE) consen sus conference on the insulin resistance syndrome. Diabetes Care 2003;26:1297-1303
5. Unger RH, Scherer PE. Gluttonysloth and the metabolic syndrome: a roadmap to lipo toxicity. Trends Endocrinol Metab. 2010 Feb 23. [E pubahead of print]. Doi:10.1016/j.tem.2010.01.009.
6. Bogardus C, Lillioja S, Mott DM, Hollen beck C, Reaven GM. Relationship between degree of obesity and in vivo insulin action in man. Amer J Physiol 1985;11:E286-91.
7. Expert Panel on Detection, Evaluation of and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program(NCEP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel III) JAMA 2001;285:2486-2497
8. Inoue S, Zimmet P. The Asia-Pacific Perspective: Redefining obesity, and its treatment. Health Communications Australia 2000:17-20.
9. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Cnal report. Circulation 2002;106:3143-3421
10. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its impli cations for policy and intervention strategies. Lancet 2004;363:157-163
11. Raji A, Seely EW, Arky RA, Siminson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001;86:5366-5371
12. Park YW, Zhu S, Palaniappan L, Heshik S, Carnethon MR, Heymsfield SB. The metabolic syndrome prevalence and associated risk factor findings in the US population from third National Health and Nutrition Examination survey, 1988-1994. Arch Intern Med 2003;163:427-436 (Pubitemid 36241019)
13. Bray GA, Jablonski, KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Amer Jour Clin Nutr 2008;87: 1212-1218
14. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Eng J Med 2002;346:393-403.